SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001274173-19-000030
Filing Date
2019-02-11
Accepted
2019-02-11 13:03:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 JANUS HENDERSON GROUP PLS OWNS <5% NOW- MEANT TO INDICATE12/31/18 IN AMENDMENT # gbt22102019.txt SC 13G/A 6589
  Complete submission text file 0001274173-19-000030.txt   8309
Mailing Address 201 BISHOPSGATE LONDON X0 EC2M 3AE
Business Address 201 BISHOPSGATE LONDON X0 EC2M 3AE 442078181818
JANUS HENDERSON GROUP PLC (Filed by) CIK: 0001274173 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Y9 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice
Assistant Director 7

Mailing Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Subject) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88976 | Film No.: 19584015
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1